Cowen and Company’s Eucrates Biomedical Acquisition Corp. Warrant EUCRW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-202,371
| Closed | -$8.2K | – | 710 |
|
|
2023
Q1 | $8.2K | Buy |
202,371
+80,114
| +66% | +$3.25K | ﹤0.01% | 394 |
|
|
2022
Q4 | $6.8K | Hold |
122,257
| – | – | ﹤0.01% | 390 |
|
|
2022
Q3 | $5K | Hold |
122,257
| – | – | ﹤0.01% | 520 |
|
|
2022
Q2 | $8K | Sell |
122,257
-64,970
| -35% | -$4.25K | ﹤0.01% | 437 |
|
|
2022
Q1 | $35K | Buy |
187,227
+8,880
| +5% | +$1.66K | ﹤0.01% | 304 |
|
|
2021
Q4 | $103K | Buy |
178,347
+140,869
| +376% | +$81.4K | 0.01% | 309 |
|
|
2021
Q3 | $27K | Hold |
37,478
| – | – | ﹤0.01% | 347 |
|
|
2021
Q2 | $39K | Sell |
37,478
-10,444
| -22% | -$10.9K | ﹤0.01% | 327 |
|
|
2021
Q1 | $60K | Buy |
+47,922
| New | +$60K | ﹤0.01% | 283 |
|